Phlorizin analogs as inhibitors of sodium glucose cotransporter 2

• 1. 作为2型钠依赖性葡萄糖转运蛋白抑制剂的新型葡萄糖衍生物 [P] . 中国专利： CN110337442A . 2019-10-15
• 2. 钠-葡萄糖协同转运蛋白2抑制剂的新用途 [P] . 中国专利： CN114099679A . 2022-03-01
• 3. Compositions containing inhibitors of sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 and methods of using the inhibitors [P] . 日本专利： JP6682460B2 . 2020-04-15

  机译： 包含钠-葡萄糖共转运蛋白1和钠-葡萄糖共转运蛋白2的抑制剂的组合物及其使用方法

• 4. PHLORIZIN ANALOGS AS INHIBITORS OF SODIUM GLUCOSE CO-TRANSPORTER 2 [P] . 韩国专利： KR101492277B1 . 2015-02-11

  机译： 辉绿素类似物作为葡萄糖钠转运蛋白2的抑制剂

• 5. PHLORIZIN ANALOGS AS INHIBITORS OF SODIUM GLUCOSE CO-TRANSPORTER 2 [P] . 韩国专利： KR20150002889A . 2015-01-07

  机译： 辉绿素类似物作为葡萄糖钠转运蛋白2的抑制剂

• 1. Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in elderly patients with comorbid coronary heart disease and diabetes mellitus [J] . Hu XU, Wen-Zhe CAO, Yong-Yi BAI, 老年心脏病学杂志（英文版） . 2021,第006期
• 2. Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats. [J] . Yamaguchi K, Kato M, Suzuki M, Drug Metabolism and Disposition: The Biological Fate of Chemicals . 2011,第10期
• 3. In-Vitro Antioxidant Activity and Free Radical Scavenging Potential of Phlorizin Derived Sodium Glucose Cotransporter 2 Inhibitor [J] . A De, P Chattopadhyay, M Singh Journal of Drug Delivery and Therapeutics . 2019,第4期
• 4. In-Vitro Antioxidant Activity and Free Radical Scavenging Potential of Phlorizin Derived Sodium Glucose Cotransporter 2 Inhibitor [J] . A De, P Chattopadhyay, M Singh Journal of Drug Delivery and Therapeutics . 2019,第4期
• 5. Polymer-Phloridzin Conjugates as an Anti-diabetic Drug that Inhibits Glucose Absorption through the Na~+/Glucose Cotransporter (SGLT1) in the Small Intestine [C] . Y. Ikumi, T. Kida, S. Sakuma, Controlled Release Society Annual Meeting and Exposition . 2007
• 6. Responses of renal hemodynamics and tubular functions to acute sodium-glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats [D] . Tuba Musarrat Ansary 2019
• 7. Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis [O] . Xiaoling Cai, Liwei Ji, Yifei Chen, 2017
• 8. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats [O] . Wang, Xueqi, Zhang, Suhua, Liu, Yang, 2013

• 1. Lesson Ninety-nine The multiple pleiotropic effects of sodium-glucose cotransporter 2 inhibitors on cardiorenal system [J] . 童鸿 . 心电与循环 . 2021,第001期
• 2. The multiple pleiotropic effects of sodium-glucose cotransporter 2 inhibitors on cardiorenal system [J] . . 心电与循环 . 2021,第001期
• 3. Sodium glucose cotransporter 2 inhibitors:New horizon of the heart failure pharmacotherapy [J] . Ryo Naito ,Takatoshi Kasai . 世界心脏病学杂志:英文版(电子版) . 2021,第9期
• 4. Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation:A review of literatures [J] . Marlene Schwarzenbach ,Flavia Elena Bernhard ,Cecilia Czerlau . 世界移植杂志 . 2021,第7期
• 5. 钠-葡萄糖2型共转运蛋白抑制剂的降糖外作用 [C] . Zhu Chao ,朱超 ,Shao Hua . 2014年中国药学大会暨第十四届中国药师周 . 2014
• 6. 钠-葡萄糖协同转运蛋白2抑制剂达格列净对急性心肌梗死后心功能的影响 [A] . 岳志泉 . 2021